Global Poliomyelitis Vaccine Market Insights Business Opportunities, Current Trends And Constraints Forecast (2019-2025) - True Version

Global Poliomyelitis Vaccine Market Insights Business Opportunities, Current Trends And Constraints Forecast (2019-2025) - True Version

Global Poliomyelitis Vaccine Market Insights Business Opportunities, Current Trends And Constraints Forecast (2019-2025) - True Version

Posted: 26 Nov 2019 08:35 PM PST

Global Poliomyelitis Vaccine Market

The Global "Poliomyelitis Vaccine" Market report offers precise analytical information about the Poliomyelitis Vaccine market. The market experts and proficient analysts generate the information based on the past and current situation of Poliomyelitis Vaccine market, various factors affecting the growth trajectory, global sales, demand, total revenue generated, and capitalization of the market. In addition, the report provides a summary assessment of the impact of federal policies and regulations on market operations. It also comprises detailed information pertaining to the Poliomyelitis Vaccine market's current dynamics. The global Poliomyelitis Vaccine market acts as a huge platform that offers several opportunities for many reputed firms, organizations, manufacturers, vendors, and suppliers (GSK, Sanofi-Pasteur, Merck, Crucell, China National Biotech Group, Eli Lilly) to compete with each other to become one of the world's leading and regional business owners.

Click Here To Access The Sample Report:: https://marketdesk.us/report/global-poliomyelitis-vaccine-market-pr/124046/#requestForSample

The global Poliomyelitis Vaccine Market 2019 report is expansive research reliant on Poliomyelitis Vaccine, which inspects the raised structure of the present Poliomyelitis Vaccine all around the globe. Arranged by the adequate methodical framework, for instance, SWOT examination, the Poliomyelitis Vaccine report exhibits a total evaluation of the significant players of the global Poliomyelitis Vaccine Market 2019. The estimates for CAGR (Compound Annual Growth Rate) is calculated by the Global Poliomyelitis Vaccine Market 2019 report in terms of extent for the specific time length. Similarly, this will help the customer to understand and to make the right choice depends on the normal chart.

A significant investigation of the market depends on overall patterns, which have been lately coordinated to the exploration of global Poliomyelitis Vaccine Market 2019, which is additionally included in the report. The report presents the demand for individual segments in each region. It demonstrates various segments Market By Technology, Regular Poliomyelitis Vaccine, Two in One Poliomyelitis Vaccine, Other, By Product, (Poliomyelitis Vaccine ? Poliomyelitis Vaccine ?, Poliomyelitis Vaccine ?, Oral Poliomyelitis Vaccine) and sub-segments Market (VAPP, VDPV) of the Poliomyelitis Vaccine. In addition, the statistical survey report makes estimates of the following market strength dependent on this investigation.

Browse Full Global Poliomyelitis Vaccine Report:: https://marketdesk.us/report/global-poliomyelitis-vaccine-market-pr/124046/#inquiry

There are 12 Chapters to display the Global Poliomyelitis Vaccine Market

Chapter 1, Definition, Specification and Classification of Poliomyelitis Vaccine, Applications of Poliomyelitis Vaccine, Market Segment by Regions;

Chapter 2, Manufacturing Cost Structure, Raw Materials and Suppliers, Manufacturing Process, Industry Chain Structure;

Chapter 3, Review of Poliomyelitis Vaccine, Capacity and Commercial Production Date, Plant Distribution, R&D Status, and Technology Origin, Raw Materials Sources Analysis, Technical Information, and Manufacturing Plants;

Chapter 4, Overall Market Analysis, Capacity Analysis (Company Segment), Sales Analysis (Company Segment), Sales Price Analysis (Company Segment);

Chapters 5 and 6, Regional Market Analysis, including the United States, China, Europe, Japan, Korea & Taiwan, Poliomyelitis Vaccine Segment Market Analysis (by Type);

Chapter 7 and 8, Segment Market Analysis (by Application) of Major Manufacturers Analysis of Segment Poliomyelitis Vaccine;

Chapter 9, Market Trend Analysis, Regional Market Trend, Market Trend by Product Type Plastic, Collodion, Other, Market Trend by Application Household Used, Commercial Used, Industrial Used;

Chapter 10, Analysis of Regional Marketing Type, Analysis of International Trade Type, Analysis of Supply Chain;

Chapter 11, Global Consumer Analysis Poliomyelitis Vaccine;

Chapter 12, Poliomyelitis Vaccine Research Findings and Conclusion, Appendix, methodology and data source;

Get Our Trending Research Reports Here:

Emerging Opportunities in Enterprise Resource Planning Erp Market with Current Trends Analysis

Global Water Based Paint Market Insight 2019 Investment Feasibility And Return Analysis

Get In Touch With Us:

420 Lexington Avenue Suite 300

New York City, NY 10170, United States

USA/Canada Tel No: +18575982522

Email: inquiry@market.biz

Website: https://marketdesk.us/

Fighting polio, one SMS at a time! - World - ReliefWeb

Posted: 08 Nov 2019 12:00 AM PST

Health workers and community volunteers in remote and security-compromised areas across 10 African countries now rely on an SMS-based application to ferret out any possible poliovirus hiding in their midst.

The application is called AVADAR, short for "auto-visual AFP detection and reporting", with AFP referring to acute flaccid paralysis, which is a visible clinical symptom of poliomyelitis. AVADAR was developed in 2016 by the World Health Organization (WHO), in collaboration with the Bill & Melinda Gates Foundation and the Swiss software company Novel-T, to ensure that every case of wild poliovirus is detected.

On a weekly basis, the health workers and volunteers in selected hard-to-reach districts use the AVADAR application to report whether they have noticed any child with paralysis of a limb. The districts are selected based on being deemed high risk yet have the sufficient telecommunications infrastructure that would allow the health workers and community volunteers to communicate with the investigations team.

"In the last mile of polio eradication, we are not sparing any resources to reach a polio-free world. That is why we developed the AVADAR app," says Dr Pascal Mkanda, WHO Regional Coordinator of the Polio Eradication Programme for Africa.

The Global Polio Eradication Initiative that was established in 1988 has managed to eradicate 99% of the poliovirus around the world. In the WHO African Region, no outbreaks of wild poliovirus have been detected since 2016, when the last case was found in Nigeria's Borno State. This brings the region closer towards being certified free of wild poliovirus in 2020.

AVADAR is an SMS-based mobile application used for reporting, monitoring and surveillance of poliovirus. Health workers and volunteers of a community use it to detect and report cases of acute flaccid paralysis, which is the sudden onset of paralysis or weakness in any part of the body that can be caused by polio, among children younger than 15 years. Acute flaccid paralysis could be caused by other diseases than poliomyelitis.

"Polio eradication requires that the surveillance system is sensitive enough to detect all acute flaccid paralysis cases -regardless of the disease behind it- and that such cases are promptly reported and investigated by disease surveillance personnel. This system starts at the community level," Dr Mkanda adds.

Health workers and community volunteers first received training in workshops on how to use AVADAR and then they were each handed a smartphone with the application installed. On a weekly basis, the app sends them video reminders illustrating acute flaccid paralysis cases. The app then asks: "Have you seen a child with weakness of the legs or arms that you have not previously reported?" They then select between yes or no. If yes, the health workers and community volunteers input extra information about the case, such as: child's name, date of onset of symptoms, geographic information and other details.

Once the health worker presses the "send" button, a text message is sent to a system that triggers the sending of an SMS to the government and WHO team that will investigate the case.

"In the AVADAR training workshops, we realized that some health workers and the majority of volunteers do not know the implications of acute flaccid paralysis and are unable to accurately identify such cases within their communities. The weekly AVADAR reminder videos helped improve that significantly," says Dr Godwin Akpan, WHO Regional Polio Data Manager for Africa.

Dr Godwin is part of the team behind the innovation of the AVADAR application and trains health workers and community members on its use.

AVADAR was first piloted in Nigeria in 2016 and has been rolled out since 2017 in 99 districts of 10 African countries: Burkina Faso, Cameroon, Chad, Democratic Republic of the Congo, Liberia, Mali, Niger, Nigeria, Sierra Leone and South Sudan.

As of October 2019, AVADAR has detected 1019 confirmed acute flaccid paralysis cases after health workers and community volunteers sent out 25,747 alerts through the application. None of those cases were polio cases. This marks a significant enhancement to the existing surveillance system that faces difficulties in remote and high-risk areas.

"Innovation and new technologies are our hope to finally make the feat of eradicating polio a reality. Thanks to the Global Polio Eradication Initiative, today, we are closer than ever to eradicating polio," concludes Dr Mkanda.

For Additional Information or to Request Interviews, Please contact:

AbdelHalim Abdallah

Polio Communications Officer\ Email: habdallah@who.int\ Tel: +201123000665 (WhatsApp)

Collins Boakye-Agyemang

Communications and marketing officer\ Tel: + 242 06 520 6565\ Email: boakyeagyemangc@who.int

Comments

Post a Comment

Popular posts from this blog

Roseola vs. measles rash: What is the difference? - Medical News Today

Image
Roseola and measles are two different diseases that present with a high fever and a rash. They are both most commonly seen in childhood, although measles can affect people of any age, and roseola in adults is very rare. While both diseases share similarities, there are distinguishing factors, such as how the symptoms present and the disease progression. Read on to find out the difference between roseola and measles rashes. Roseola, also known as roseola infantum, sixth disease, or exanthema subitum, is a viral infection that typically affects children. The human herpesvirus 6 (HHV-6) or human herpesvirus 7 (HHV-7) causes roseola. The disease is spread through tiny respiratory droplets that people either breathe in or pick up from surfaces they touch. This disease usually presents in children between the ages of 6–12 months . Children who have this disease experience a high fever, followed by a pink or red rash. Roseola is a self-limiting viral illness, meaning it will typically go awa...
Read more

poliomyelitis treatment

Image
poliomyelitis treatment Drug and Device News March 2019 - P&T Community Posted: 04 Mar 2019 10:35 AM PST NEW DRUG APPROVALS Ontruzant, a Herceptin Biosimilar The FDA has approved trastuzumabdttb (Ontruzant, Samsung Bioepis Company, Ltd.) for HER2-overexpressing breast cancer and HER2-overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma. Trastuzumabdttb, a HER2/neu receptor antagonist, is the third FDA-approved biosimilar of Herceptin (Genentech). Patients should be selected for therapy based on an FDA-approved companion diagnostic. Trastuzumab-dttb carries a boxed warning about the risks of cardiomyopathy, serious and fatal infusion reactions, embryo-fetal toxicity, and pulmonary toxicity. Ontruzant will be marketed and distributed in the U.S. by Merck. Sources: Samsung Bioepis, January 21, 2019; Ontruzant . prescribing information, January 2019; FDA, January 18, 2019 Vaxelis, a Combination Vaccine T...
Read more

Coronavirus fake news echoes century-old polio fears - Newsroom

Image
Coronavirus fake news echoes century-old polio fears - Newsroom Coronavirus fake news echoes century-old polio fears - Newsroom Posted: 05 Feb 2020 08:32 AM PST FEBRUARY 6, 2020 Updated 15 hours ago Dr Heather Battles Dr Heather Battles is a lecturer in anthropology at the University of Auckland and researches infectious diseases and epidemics. Show more Ideasroom During the past month, in the confusion and uncertainty over the precise origin of the 2019 novel coronavirus outbreak, many alternate ideas or 'conspiracy theories' have sprung up and spread widely via social media including Twitter and Facebook. I have had a sense of déjà vu as many of these claims have parallels in how people responded to another 'emerging' epidemic disease a century ago: polio. The first example that struck me is the idea (spread by US fake news website Infowars and others) that the roll-out of 5G technology is to blame, wit...
Read more